ERBB2 and cancer: Our immunocytochemistry (ICC) and Western blot analysis demonstrated strong expression of HER2 protein by SK-BR3, BT474, and MDA-MB361 cancer cells compared to MDA-MB231 and MDA-MB468 cancer cells (Figure 1 and Figure 2).